Use the calculators result as a starting point for discussion with your doctor or telehealth clinician
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
These strategies, combined with tirzepatide, can create a synergistic effect that enhances overall health and well-being
According to the American Cancer Society, warning signs can include blood in the stool, unexplained weight loss, persistent abdominal pain, anemia, or bowel changes that dont improve over time
When administered, it binds to GHRH receptors on the pituitary gland, triggering a cascade of events that leads to the synthesis and release of HGH
& Taschler, U